Hypothesis

The functional age of the gut microbiome drives brain senescence via microbiota‑derived phenylacetic acid (PAA) that induces p16‑positive astrocyte senescence, creating a microbial clock that accelerates inflammaging.

Mechanistic Rationale

Age‑related gut dysbiosis increases circulating lipopolysaccharides, activating TLR/NF‑κB signaling in astrocytes and raising blood‑brain barrier permeability [gut dysbiosis drives neuroinflammation]. Concurrently, senescent astrocytes release SASP factors that compromise gut barrier integrity, allowing microbial metabolites to enter circulation [brain astrosenescence promotes gut permeability]. We propose that an overlooked output of this loop is the microbial production of phenylacetic acid, a metabolite shown to directly trigger cellular senescence in peripheral tissues [PAA induces senescence]. When PAA crosses a leaky BBB, it engages NF‑κB in astrocytes, upregulating p16 and SASP, which then further damages the gut epithelium. Thus the microbiome’s functional age—reflected in its capacity to produce senescence‑inducing metabolites—acts as a upstream driver of brain aging.

Testable Predictions

1. Transfer of microbiota from aged donors to germ‑free young mice will elevate fecal and circulating PAA, increase astrocytic p16‑positive cells, and heighten neuroinflammatory markers compared with transfer from young donors.
2. Direct administration of physiological concentrations of PAA to young mice will recapitulate astrocyte senescence and gut barrier leakage without altering microbiota composition.
3. Time‑restricted eating (TRE) reduces the functional age of the microbiome (lower PAA production) and, when combined with the senolytic dasatinib+quercetin (D+Q), yields a greater reduction in astrocytic p16‑SASP and improves cognition than either intervention alone.

Experimental Design

• Cohorts: Young (3 mo) germ‑free mice receiving fecal transplants from aged (24 mo) or young donors; PAA‑treated young mice; aged mice undergoing TRE (10‑h feeding window) for 8 weeks; aged mice receiving D+Q (5 mg/kg dasatinib + 50 mg/kg quercetin, i.p., weekly); aged mice receiving combined TRE + D+Q.
• Readouts: Fecal and plasma PAA quantified by LC‑MS; astrocyte isolation followed by flow cytometry for p16 and GFAP; SASP cytokine panel (IL‑1β, IL‑6, TNF‑α); gut permeability assessed by FITC‑dextran assay; behavioral tests (Morris water maze, novel object recognition); 16S rRNA sequencing to compute a microbiome age score using published clocks.
• Analysis: Two‑way ANOVA for interactions between microbiota source/TRE/D+Q; post‑hoc tests with Bonferroni correction.

Potential Outcomes

If the microbial clock hypothesis is correct, aged‑microbiota transplants and PAA exposure will increase astrocytic p16 and impair cognition, while TRE will lower microbiome age scores and PAA levels, and D+Q will clear existing senescent astrocytes. The combined TRE + D+Q group should show the lowest PAA, astrocytic senescence, and behavioral deficits, demonstrating that targeting both directions of the gut‑brain axis disrupts the self‑reinforcing loop. Failure to observe these changes would falsify the hypothesis, indicating that microbiome‑derived PAA is not a primary driver of astrocyte senescence in aging.

Significance

Demonstrating a microbiome‑derived senescence signal would shift focus from host‑centric inflammaging to a tractable, modifiable microbial clock, opening preventive strategies that synchronize dietary rhythms with senolytic clearance to extend healthspan.